Scientists create organoid to understand hearing loss
The ground-breaking study is an important step towards modelling cochlear function in a dish.
List view / Grid view
The ground-breaking study is an important step towards modelling cochlear function in a dish.
The team used these models to show drug responses and established a CRISPR-screening platform to identify potential therapeutic targets for non-alcoholic fatty liver disease.
By creating a drug that is based on part of the SARS-CoV-2 spike protein, US and Finnish researchers can block the virus from entering cells.
To help people with opioid addiction, US researchers are turning to AI to create and optimise potential new drugs.
Proteomic platform developed by US scientists affords a greater insight into the dynamics of iron-sulphur clusters delivery and binding.
Japanese researchers combine cutting edge mass spectrometry with software analysis to elucidate mRNA structure.
US researchers evaluate an experimental gene therapy in the first ever nonhuman primate model for Usher Syndrome.
US researchers investigate how bacteria develop an antibiotic tolerance without mutations.
US researchers spotlight how p53, the most frequently mutated tumour suppressor gene, can be activated against cancer cells.
Australian researchers have uncovered why some forms of Streptococcus A (Strep A) are associated with severe invasive infection.
The resulting compounds, which can bind to spike proteins from the original coronavirus, could serve as a starting point for developing broad-spectrum treatments for COVID-19.
US researchers uncover the amino acid: arginine, that prompts genetic mutations in cancer cells.
A new approach using CAR T-cell therapy is suggested by Swedish researchers as an effective treatment for ovarian cancer.
US scientists have outlined the structure and function of the first FDA approved drug for the Ebola virus.
US researchers found that serotonin impacts the mitral valve in the heart which can lead to heart valve disease.